Jimmy John's Salmonella Sprouts Investigation Extends Beyond IL IN MO
Jimmy John's is based in Illinois but the Salmonella sprouts investigation that began there now extends well beyond Illinois' borders. Fifteen states and the District of Columbia have reported a total of 89 individuals with a matching strain of Salmonella type I 4,(5), 12:i:-. To date, only Jimmy John's restaurants in Illinois have been reported as associated with this outbreak.
Jimmy John's has confirmed the Salmonella outbreak investigation and pulled sprouts from menus in Illinois. The illnesses began November 1 and the onset of the most recent case was December 21. The Center for Disease Control and Prevention (CDC) said preliminary results of the investigation indicate a link to eating alfalfa sprouts at a national sandwich chain. Illinois, Missouri and Indiana are the leading states.
This multi-state outbreak of Salmonella associated with sprouts at Jimmy John's is also under investigation by law firm PritzkerOlsen, P.A., and a claims center for members of the public can be contacted at 1-888-377-8900 (Toll Free) or via the contact form on the side of this Web page. A Jimmy John's lawsuit likely will result, but liability could extend to the producer of any contaminated sprouts.
According to the CDC, since 1996, there have been at least 30 reported outbreaks of foodborne illness associated with different types of raw and lightly cooked sprouts. Most of these outbreaks were caused by Salmonella and E. coli.
The number of ill people identified in each state with the outbreak strain is as follows: Illinois (5), Missouri (14) Indiana (9) Connecticut (1), District of Columbia (1), Georgia (1), Hawaii (1), Iowa (1), Massachusetts (1), New York (1), Pennsylvania (2), South Dakota (1), Tennessee (1), Texas (1), Virginia (1), and Wisconsin (3). The Food and Drug Administration is helping CDC track the source of the outbreak using genetic fingerprint testing of food samples.
CDC says case-patients range in age from 1 to 75 years, with a median age of 28. Sixty-eight percent of patients are female. Among persons with available information, 23% reported being hospitalized. No deaths have been reported.
